Medicare Reimbursement Attributable to Periprosthetic Joint Infection Following Primary Hip and Knee Arthroplasty

The Journal of Arthroplasty
Sarah H YiJohn A Jernigan

Abstract

This study estimated Medicare reimbursement attributable to periprosthetic joint infection (PJI) across the continuum of covered services four years following hip or knee arthroplasty. Using 2001-2008 Medicare claims data, total and annual attributable reimbursements were assessed using generalized linear regression, adjusting for potential confounders. Within one year following arthroplasty, 109 (1.04%) of 10,418 beneficiaries were diagnosed with PJI. Cumulative Medicare reimbursement in the PJI arm was 2.2-fold (1.9-2.6, P<.0001) or $53,470 ($39,575-$68,221) higher than that of the non-PJI arm. The largest difference in reimbursement occurred the first year (3.2-fold); differences persisted the second (2.3-fold) and third (1.9-fold) follow up years. PJI following hip or knee arthroplasty appears costly to Medicare, with cost traversing several years and health care service areas.

References

Sep 12, 1996·The New England Journal of Medicine·M E GornickB C Vladeck
Jun 3, 1999·Annual Review of Public Health·P DiehrD Y Lin
Aug 9, 2005·The Journal of Bone and Joint Surgery. American Volume·Kevin J Bozic, Michael D Ries
Mar 21, 2007·Rheumatic Diseases Clinics of North America·C Allyson JonesMaria E Suarez-Almazor
Jun 7, 2008·The Journal of Arthroplasty·Steven M KurtzJavad Parvizi
Apr 2, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Maureen K BolonUNKNOWN Centers for Disease Control and Prevention Epicenters Program
Jun 6, 2009·The Journal of Arthroplasty·Kevin L OngJavad Parvizi
Jun 24, 2009·Archives of Internal Medicine·Elena LosinaJeffrey N Katz
Aug 15, 2009·The Journal of Arthroplasty·Matthew HellmannJonathan M Zenilman
Jun 24, 2010·The Journal of Arthroplasty·Kevin J BozicDaniel J Berry
Jan 7, 2011·Journal of Clinical Epidemiology·Joshua J GagneSebastian Schneeweiss
Jan 13, 2011·Journal of Evaluation in Clinical Practice·Parham DaneshvarGeoffrey F Dervin
Apr 21, 2011·JAMA : the Journal of the American Medical Association·Peter CramYue Li
Jul 5, 2011·The Journal of Rheumatology·Jasvinder A SinghPeter Tugwell
Jan 1, 2008·Journal of Pain & Palliative Care Pharmacotherapy· National Quality Measures Clearinghouse, Agency For Healthcare Research And Quality
Dec 17, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Michael S CalderwoodUNKNOWN CDC Prevention Epicenters Program
May 5, 2012·The Journal of Arthroplasty·Jasvinder A Singh, David G Lewallen
May 5, 2012·The Journal of Arthroplasty·Steven M KurtzJavad Parvizi
Oct 9, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Elizabeth Bryce, Leslie Forrester
Dec 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Douglas R OsmonUNKNOWN Infectious Diseases Society of America
May 29, 2013·The Journal of Arthroplasty·Scott T LovaldSteve M Kurtz
Aug 6, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deborah S YokoeSusan S Huang
Feb 14, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sandra I Berríos-TorresJohn A Jernigan

❮ Previous
Next ❯

Citations

May 2, 2018·The Journal of Bone and Joint Surgery. American Volume·Timothy L TanJavad Parvizi
Aug 31, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Hannah M WolfordRachel B Slayton
Nov 10, 2017·Journal of Bone and Joint Infection·Christian LausmannMatthias Gebauer
Jun 4, 2017·Der Unfallchirurg·C Willy, A Trampuz
Aug 28, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Gregory J KirchnerLucas E Nikkel
May 27, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jill G DreyfusMargaret A Olsen
Aug 20, 2021·BMC Musculoskeletal Disorders·Charles OkaforJoshua Byrnes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.